bodyweight decreased and quality of life improved after 24 weeks in the total cohort . though the findings are limited by number of patients , still the trend indicates that insulin analogues can be considered effective and possess a safe profile for treating type 2 diabetes in oriental morocco .
a1chieve , a multinational , 24-week , non - interventional study , assessed the safety and effectiveness of insulin analogues in people with t2 dm ( n = 66,726 ) in routine clinical care .
our study reports improved glycaemic control following 24 weeks of treatment with any of the insulin analogues ( biphasic insulin aspart ; insulin detemir ; insulin aspart ) with or without ogld .
other groups were insulin detemir ( n = 22 ) , insulin aspart ( n = 6 ) , basal insulin plus insulin aspart ( n = 2 ) and other insulin combinations ( n = 4 ) . overall demographic data after 24 weeks of treatment , overall hypoglycaemia decreased for both insulin user ( from 30.1 events / patient - year to 13.8 events / patient - year ) and insulin nave ( from 24.9 events / patient - year to 12.7 events / patient - year ) groups .